Reporting of medication information in applied studies of people with autism

Research in Autism Spectrum Disorders

Volumn 5, Issue 1, 2011, Pages 108-111

  Weeden, Marc ^a   Porter, Lindsay K ^a   Durgin, Amy ^a   Redner, Ryan N ^a   Kestner, Kathryn M ^a   Costello, MacK ^a   Cleary, Kathleen ^a   Edwards, Timothy L ^a   Hayes, Sarah M ^a   Poling, Alan ^a  

^a WESTERN MICHIGAN UNIVERSITY   (United States)

Author keywords

Autism; Behavior change interventions; Medication; Participant characteristics; Psychotropic medication; Research methods

Indexed keywords

PSYCHOTROPIC AGENT;

ARTICLE; AUTISM; BEHAVIOR CHANGE; BEHAVIOR THERAPY; DRUG INFORMATION; HUMAN; MEDICAL LITERATURE; PRIORITY JOURNAL;

EID: 77957357558     PISSN: 17509467     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rasd.2010.02.005     Document Type: Article

References (35)

1. M. Agran, S. Moore, and J. Martin Research in mental retardation: Underreporting of medication information Research in Developmental Disabilities 9 1988 351 357
2. M.G. Aman, K.S. Lam, and A. Collier-Crespin Prevalence and patterns of use among individuals with autism in the Autism Society of Ohio Journal of Autism and Developmental Disorders 33 2003 525 534
3. J.W. Bodfish Treating the core features of autism: Are we there yet? Mental Retardation and Developmental Disabilities Research Reviews 10 2004 318 326
4. L. Christian, C.L. Kerr, G.E. Sutphin, and A. Poling Reporting of medication regimen in applied studies of persons with mental retardation and ADHD Research in Developmental Disabilities 18 1997 319 327
5. K.A. Crosland, J.R. Zarcone, S.E. Lindauer, M.G. Valdovinos, T.J. Zarcone, and J.A. Hellings Use of functional analysis methodology in the evaluation of medication effects Journal of Autism and Developmental Disabilities 33 2003 271 279
6. D. Delaney, and A. Poling Reporting of medication regimen as a subject characteristic in behavior modification studies with mentally retarded participants published from 1984-1988 Developmental Disabilities Bulletin 18 1990 14 19
7. W. Fisher, C.C. Piazza, and T.J. Page Assessing independent and interactive effects of behavioral and pharmacological interventions for a client with dual diagnoses Journal of Behavior Therapy and Experimental Psychiatry 20 1989 241 250
8. K. Francis Autism interventions: A critical update Developmental Medicine & Child Neurology 47 2005 493 499
9. R.P. Goin-Kochler, B.J. Myers, and V.H. Mackintosh Parental reports on the use of treatments and therapies for children with autism spectrum disorders Research in Autism Spectrum Disorders 1 2007 195 209
10. V.A. Green, K.A. Pituch, J. Itchen, A. Choi, M. O'Reilly, and J. Sigafoos Internet survey of treatments used by parents of children with autism Research in Developmental Disabilities 27 2006 70 84
11. P. Gringras Practical pediatric psychopharmacological prescribing in autism: The potential and the pitfalls Autism 4 2000 229 247
12. L.P. Hagopian, and M.E. Anderson Integrating behavioral and pharmacological interventions for severe problem behavior displayed by children with neurogenetic and developmental disorders B.K. Shapiro, P.J. Accardo, Neurobehavioral disorders: Behavioral issues and their treatment 2010 Brookes New York 219 239
13. B.H. King Pharmacological treatment of mood disturbance, aggression and self-injury in persons with pervasive developmental disorders Journal of Autism and Developmental Disorders 30 2000 439 445
14. K.S. Langworthy-Lam, M.G. Aman, and M.E. Van Bourgondien Prevalence and patterns of use of psychoactive medicines in individuals with autism in the Autism Society of North Carolina Journal of Child and Adolescent Psychopharmacology 12 2002 311 321
15. Matson, J. A., Mayville, E. A. (Eds.). (in press). Behavioral foundations of effective autism treatment. New York: Sloan.
16. C.J. McDougle, and D.J. Posey Autistic and other pervasive developmental disorders A. Martin, L. Scahill, D.S. Charney, J.F. Leckman, Paediatric psychopharmacology: Principles and practices 2002 Oxford University Press Oxford 563 579
17. C.M. Morini, C. Colecchi, J. Stone, R. Sood, and D. Brink Behavioral and pharmacological therapies for late-life insomnia Journal of the American Medical Association 281 1999 991 999
18. S. Moussavand, and R.L. Fielding Recent advances in the pharmacological treatment of pervasive developmental disorders Current Pediatric Reviews 3 2007 79 91
19. S.M. Myers The status of pharmacotherapy for autism spectrum disorders Expert Opinion on Pharmacotherapy 8 2007 1579 1603
20. S.M. Myers, and C.P. Johnson Management of children with autism spectrum disorders Pediatrics 120 2007 1162 1182
21. J. Northup, I. Fusilier, V. Swanson, J. Huete, T. Bruce, and J. Freeland Further analysis of the separate and interactive effects of methylphenidate and common classroom contingencies Journal of Applied Behavior Analysis 32 1999 35 50
22. J. Northup, I. Fusilier, V. Swanson, H. Roane, and J. Borrero An evaluation of methylphenidate as a potential establishing operation for some common classroom reinforcers Journal of Applied Behavior Analysis 30 1997 615 625
23. W.E. Pelham Jr., E.M. Gnagy, A.R. Greiner, B. Hoza, S.P. Hinshaw, and J.M. Swanson Behavioral versus behavioral and pharmacological treatment in ADHD children attending a summer treatment program Journal of Abnormal Child Psychology 28 2000 507 525
24. Poling, A., Ehrhardt, K., Wood, A., & Bowerman, R. (in press). Psychopharmacology and behavior analysis in autism treatment. In J. A. Matson & E. A. Mayville (Eds.), Behavioral foundations of effective autism treatment. New York: Sloan.
25. A. Poling, D. Grossett, C. Karas, and S.E. Breuning Medication regimen: A subject characteristic rarely reported in behavior modification studies Applied Research in Mental Retardation 6 1985 71 77
26. D.A.M. Pyles, K. Muniz, A. Cade, and R. Silva A behavioral diagnostic paradigm for integrating behavior-analytic and psychopharmacological interventions for people with a dual diagnosis Research in Developmental Disabilities 18 1997 185 214
27. P.J. Santosh, and G. Baird Pharmacotherapy of target symptoms in autistic spectrum disorders Indian Journal of Pediatrics 68 2001 427 431
28. S.R. Schroeder, M.H. Lewis, and M.A. Lipton Interactions of pharmacotherapy and behavior therapy among children with learning and behavioral disorders Advances in Learning and Behavioral Disabilities 2 1983 179 229
29. R.J. Steingard, D.F. Conner, and T. Au Approaches to psychopharmacology M.L. Bauman, T.L. Kemper, The neurobiology of autism 2005 Johns Hopkins University Press Baltimore, MD 79 102
30. T. Thompson, T. Moore, and F. Symons Psychotherapeutic medications for positive behavior support S. Odom, R. Horner, M. Snell, J. Blacher, Handbook of developmental disabilities 2007 Guilford New York 501 528
31. R.E. Towbin Strategies for pharmacologic treatment of high functioning autism and Asperger syndrome Child and Adolescent Psychiatry Clinics of North America 12 2003 23 45
32. L.V. Tsai Taking the mystery out of medications in autism/Asperger's syndrome 2001 Future Horizons Arlington, TX
33. M. Weeden, K. Ehrhardt, and A. Poling Conspicuous by their absence: Studies comparing and combining risperidone and applied behavior analysis to reduce challenging behavior in children with autism Research in Autism Spectrum Disorders 3 2009 905 912
34. A. Witwer, and L. Lecavalier Treatment incidence and patterns in children and adolescents with autism spectrum disorders Journal of Child and Adolescent Psychopharmacology 15 2005 671 681
35. J.R. Zarcone, S.E. Lindauer, P.S. Morse, K.A. Crosland, M.G. Valdovinos, and T.L. McKerchar Effects of risperidone on destructive behavior of persons with developmental disabilities: III. Functional analysis American Journal on Mental Retardation 109 2004 310 321